GALT
Galectin Therapeutics Inc
3.90$
-1.5%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
Galectin Therapeutics Inc (GALT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -2.4 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -7.6 | -4.7 | -12 | -8.3 | -8.5 | -13 | -7.7 | -6.6 | -3.5 | -6.0 | -3.9 | -2.4 | -16 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.1 | |
| 0.6 | 0.5 | 0.6 | 0.7 | 0.5 | 0.6 | 0.5 | 0.5 | 0.5 | 0.2 | 0.7 | 1.0 | 2.3 | |
| 1.5 | 4.9 | -2.3 | 3.2 | 1.1 | 0.3 | 1.1 | -1.0 | 1.7 | -1.2 | 1.3 | 2.5 | 4.3 | |
| 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| – | 0.1 | 0.1 | – | 0.0 | 0.1 | 0.1 | – | 0.0 | 0.1 | 0.1 | – | – | |
| – | 0.4 | 0.3 | – | 0.6 | – | – | – | 0.2 | 0.2 | – | – | – | |
| – | – | – | – | 10 | 0.0 | 0.0 | 11 | 0.0 | 10 | – | – | – | |
| 10 | 10 | 10 | 10 | 10 | 0.9 | 0.0 | 13 | 1.3 | 12 | 0.3 | 1.6 | 15 | |
| 2.4 | 5.3 | -2.1 | 2.0 | 1.5 | -12 | -7.7 | 6.3 | -2.2 | 6.2 | -3.6 | -0.8 | -0.5 | |
| -7.6 | -4.7 | -12 | -8.3 | -8.5 | -13 | -7.7 | -6.6 | -3.5 | -6.0 | -3.9 | -2.4 | -16 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.